Bank of Montreal
AIM

Bank of Montreal’s AIM ImmunoTech AIM Stock Holding History

Bank of Montreal’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$11K – 5572
2021
Q1 		$11K Buy
+50
New +$11.3K ﹤0.01% 4357
2020
Q4 		– Hold
0
– – – 5272
2020
Q3 		– Hold
0
– – – 5058
2020
Q2 		– Hold
0
– – – 4997
2020
Q1 		– Hold
0
– – – 5146
2019
Q4 		– Hold
0
– – – 5174
2019
Q3 		– Hold
0
– – – 5215
2019
Q2 		– Hold
0
– – – 5259
2019
Q1 		– Hold
0
– – – 5143
2018
Q4 		– Hold
0
– – – 5067
2018
Q3 		– Hold
0
– – – 5065
2018
Q2 		– Hold
0
– – – 5040
2018
Q1 		– Hold
0
– – – 4545
2017
Q4 		– Hold
0
– – – 4524
2017
Q3 		– Hold
0
– – – 4520

Other funds holding AIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Bank of Montreal's AIM Position: Q2 2021 in Review

Bank of Montreal sold out of AIM ImmunoTech (AIM) in Q2 2021, closing a stake of 50 shares — an estimated $11K sold.

Bank of Montreal first reported a position in AIM in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 35 funds tracked by Wall St. Rank hold AIM as of Q2 2021.

  • Bank of Montreal reported no remaining AIM ImmunoTech position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 50 AIM ImmunoTech shares in Q2 2021, an estimated $11K.
  • Bank of Montreal first reported a position in AIM ImmunoTech in Q1 2021 and held it in 1 quarter.
  • Bank of Montreal's AIM ImmunoTech position peaked at $11K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.